Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Detox Support: May contribute to the body's ability to process and eliminate toxins, promoting a smoother detoxification experience
We hope that the peptide drug developed in this study could be a viable option for second-line adjuvant tumor therapy
They are not intended to represent clinical evidence in humans, and AOD-9604 has not been approved by the FDA, EMA, or any other regulatory authority for any indication
Critical supporting codes that should accompany the E66 primary diagnosis include: Z68.30 through Z68.45 - BMI codes specifying the exact range (Z68.35 = BMI 35.0-35.9, Z68.41 = BMI 41.0-44.9, etc.) I10 - Essential hypertension (a qualifying comorbidity) E78.5 - Hyperlipidemia, unspecified (another qualifying comorbidity) G47.33 - Obstructive sleep apnea (a qualifying comorbidity) E11.9 - Type 2 diabetes (if present as comorbidity) Loading the claim with all applicable comorbidity codes significantly improves the chances of first-pass approval
US$ 25.82
US$ 29.31
US$ 25.24
US$ 26.09
US$ 27.06
US$ 25.91
US$ 29.05
US$ 24.87
US$ 23.92
US$ 27.51
US$ 24.02